seletracetam and Parkinson-Disease

seletracetam has been researched along with Parkinson-Disease* in 1 studies

Reviews

1 review(s) available for seletracetam and Parkinson-Disease

Article	Year
Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy. Current opinion in investigational drugs (London, England : 2000), 2008, Volume: 9, Issue:1 UCB SA was developing the high-affinity synaptic vesicle glycoprotein 2A ligand, seletracetam, an analog of levetiracetam, for the potential oral treatment of epilepsy. Phase II epilepsy trials were underway, but in July 2007, the company stated that development of seletracetam had been put on hold and it is unknown whether planned phase IIb/III trials will begin. Topics: Animals; Anticonvulsants; Epilepsy; Humans; Parkinson Disease; Pyrrolidinones; Structure-Activity Relationship	2008

Article

Year

Seletracetam, a small molecule SV2A modulator for the treatment of epilepsy.

Current opinion in investigational drugs (London, England : 2000), 2008, Volume: 9, Issue:1

UCB SA was developing the high-affinity synaptic vesicle glycoprotein 2A ligand, seletracetam, an analog of levetiracetam, for the potential oral treatment of epilepsy. Phase II epilepsy trials were underway, but in July 2007, the company stated that development of seletracetam had been put on hold and it is unknown whether planned phase IIb/III trials will begin.

Topics: Animals; Anticonvulsants; Epilepsy; Humans; Parkinson Disease; Pyrrolidinones; Structure-Activity Relationship

2008